Lower Insulin Costs Now Act
Latest action · Dec 18, 2019 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedDec 17, 2019
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
This bill requires the Food and Drug Administration (FDA) to continue to review applications for certain biological products under an earlier review process, notwithstanding recent FDA guidance. (A 2009 law established a new procedure for approving biological products but allowed certain products in an already approved product class to receive approval under the earlier procedure until March 23, 2020; subsequently, in December 2018, the FDA issued guidance stating that an application filed under the earlier procedure that is not approved by March, 23, 2020, will not be approved.)
The bill requires the FDA to continue reviewing an application filed not later than March 23, 2019, under the earlier procedure, even if it was not approved as of March 23, 2020.
Such an application not approved after October 1, 2022, shall be deemed withdrawn.
Such an approved application shall be deemed a biological product license.
Cosponsors 6
Members who signed on, in the order they did. Signatures ran from Dec 17, 2019 to Dec 23, 2019, with 4 there on the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-MI | Andy Levin | Original | Dec 17, 2019 |
| R-KY | Brett Guthrie | Original | Dec 17, 2019 |
| D-IL | Janice D. Schakowsky | Original | Dec 17, 2019 |
| R-PA | Mike Kelly | Original | Dec 17, 2019 |
| R-PA | Brian K. Fitzpatrick | Dec 18, 2019 | |
| R-PA | Scott Perry | Dec 23, 2019 |
Actions 3
Everything that happened, newest first.
- Dec 18, 2019Referred to the Subcommittee on Health.
- Dec 17, 2019Introduced in House
- Dec 17, 2019Referred to the House Committee on Energy and Commerce.
Related bills 2
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 19 | Lower Costs, More Cures Act of 2019 | Related bill | Dec 19, 2019 |
| HR 1865 | Further Consolidated Appropriations Act, 2020 | Related bill | Dec 20, 2019 |
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Dec 17, 2019Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.